Amanote Research
Register
Sign In
Financial Incentives for Antipsychotic Depot Medication: Ethical Issues
Journal of Medical Ethics
- United Kingdom
doi 10.1136/jme.2006.016188
Full Text
Open PDF
Abstract
Available in
full text
Categories
Arts
Humanities
Legal Aspects
Health Policy
Health
Ethics
Issues
Date
April 1, 2007
Authors
D. Claassen
Publisher
BMJ
Related search
Systematic Review of Patient and Nurse Attitudes to Depot Antipsychotic Medication
British Journal of Psychiatry
Medicine
Psychiatry
Mental Health
Bioethical Issues in Providing Financial Incentives to Research Participants
Medicolegal and Bioethics
Treatment Adherence and Social Functioning in Patients Diagnosed With Schizophrenia and Treated With Antipsychotic Depot Medication
Medicine and Pharmacy Reports
Medicine
High-Dose Antipsychotic Medication
British Journal of Psychiatry
Medicine
Psychiatry
Mental Health
Cholinergic Medication for Antipsychotic-Induced Tardive Dyskinesia
BJ Psych Advances
Psychiatry
Mental Health
High Dose Antipsychotic Medication
Psychiatric Bulletin
Keeping Ethical Investment Ethical: Regulatory Issues for Investing for Sustainability
Journal of Business Ethics
Arts
Management
Business
Humanities
Economics
International Management
Accounting
Law
Econometrics
Use of High Dose Antipsychotic Medication
Psychiatric Bulletin
Aripiprazole Use Combined With Depot Antipsychotic Medication: Two Cases Demonstrating Its Ability to Reduce Prolactin Levels in an Adolescent Forensic Hospital
Therapeutic Advances in Psychopharmacology
